WuXi AppTec Investor

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Technology: Biotechnology, Health Care, Medical Device, Outsourcing, Pharmaceutical
Industry: Longevity Industry 2022
Headquarters: Shanghai, Shanghai, China
Founded Date: 2000-12-01
Employees Number: 10001+
Funding Status: IPO
Number Of Exits: 6
Acquisitions Number: 6
Investors Number: 5
Total Funding: 1593470000
Estimated Revenue: $100M to $500M
Last Funding Date: 2016-03-06
Last Funding Type: Debt Financing

Visit Website
tech@4abio.com
https://twitter.com/WuXi_AppTec
Register and Claim Ownership